Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis

Carcinogenesis

Volumn 29, Issue 6, 2008, Pages 1108-1114

  Kataoka, Ken ^a   Kim, Dae Joon ^a   Carbajal, Steve ^a   Clifford, John L ^a   DiGiovanni, John ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; GENE DISRUPTION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN TUMOR; TRANSCRIPTION INITIATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; TAMOXIFEN; TETRADECANOYLPHORBOL ACETATE;

EID: 46949083070     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn061     Document Type: Article

References (36)

1. Bowman, T. et al. (2000) STATs in oncogenesis. Oncogene, 19, 2474-2488.
2. Bromberg,J. (2002) Stat proteins and oncogenesis. J. Clin. Invest. 109, 1139-1142.
3. Levy,D.E. et al. (2002) Stats: Transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol., 3, 651- 662.
4. Levy,D.E. et al. (2002) What does Stat3 do? J. Clin. Invest. 109, 1143-1148.
5. Darnell,J.E. Jr. (1997) STATs and gene regulation. Science, 277 1630-1635.
6. Bromberg,J.F. et al. (1999) Stat3 as an oncogene. Cell, 98, 295-303.
7. Turkson,J. et al. (2000) STAT proteins: Novel molecular targets for cancer drug discovery. Oncogene, 19, 6613-6626.
8. Kim,D.J. et al. (2007) Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Mol. Carcinog. 46, 725-731.
9. Sano,S. et al. (2008) Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases. J. Dermatol. Sci., 50, 1-14.
10. Chan,K.S. et al. (2004) Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res., 64, 2382-2389.
11. Chan,K.S. et al. (2004) Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J. Clin. Invest., 114, 720-728.
12. Chan,K.S. et al. (2008) Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene, 27, 1087-94.
13. Feil,R. et al. (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun., 237, 752-757.
14. DiGiovanni,J. et al. (2000) Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res., 60, 1561-1570.
15. Sano,S. et al. (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J., 18, 4657-4668.
16. Metzger,D. et al. (2001) Site- and time-specific gene targeting in the mouse. Methods, 24, 71-80.
17. Utomo,A.R. et al. (1999) Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat. Biotechnol., 17, 1091-1096.
18. Garcia-Otin,A.L. et al. (2006) Mammalian genome targeting using site-specific recombinases. Front. Biosci., 11, 1108-1136.
19. Spiegelman,B.M. (1998) PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes, 47, 507-514.
20. He,W. et al. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl Acad Sci. USA, 100, 15712-15717.
21. Imai,T. et al. (2004) Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl Acad. Sci. USA, 101, 4543-4547.
22. McLean,G.W. et al. (2004) Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev., 18, 2998-3003.
23. Mallo,M. (2006) Controlled gene activation and inactivation in the mouse. Front. Biosci., 11, 313-327.
24. Kroll,J. et al. (2003) Versatile inducible activation system of Akt/PKB signaling pathway in mice. Genesis, 35, 160-163.
25. Petrich,B.G. et al. (2003) Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination. FASEB J., 17, 749-751.
26. Indra,A.K. et al. (1999) Temporally-controlied site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res., 27, 4324-4327.
27. Sano,S. et al. (2005) Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res., 65, 5720-5729.
28. Aoki,Y. et al. (2003) Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood, 101, 1535-1542.
29. Kanda,N. et al. (2004) STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene, 23, 4921-4929.
30. Catlett-Falcone,R. et al. (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10, 105-115.
31. Epling-Burnette,P.K. et al. (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest., 107, 351-362.
32. Gritsko,T. et al. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin. Cancer Res., 12, 11-19.
33. Li,L. et al. (2002) Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines. J. Biol. Chem., 277, 17397-17405.
34. DeArmond,D. et al. (2003) Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines. Oncogene, 22, 7781-7795.
35. Mora,L.B. et al. (2002) Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res., 62, 6659-6666.
36. Alvarez,J.V. et al. (2006) Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor. Cancer Res., 66, 3162-3168.